HMGB1 and diabetes mellitus: In this study, we have provided evidence that treatment with neutralizing anti-HMGB1 antibodies significantly attenuates BBB disruption and morphological alterations induced by brain I/R injury in combination with DM; this suggests that anti-HMGB1 antibodies exert a protective effect on diabetic stroke injury.